b Methicillin-resistant Staphylococcus aureus (MRSA) is a notorious human pathogen that can cause a broad spectrum of infections. MRSA strains are resistant to almost the entire family of ␤-lactam antibiotics due to the acquisition of staphylococcal cassette chromosome mec (SCCmec). The chromosome cassette recombinases A and B, encoded by ccrAB genes located on SCCmec, play a key role in the excision of SCCmec. Studies have shown that ccrAB genes are expressed in only a minority of cells, suggesting the involvement of a subtle regulatory mechanism in ccrAB expression which has not been uncovered. Here, we found that an inverted repeat (IR) element, existing extensively and conservatively within the ccrAB promoter of different SCCmec types, played a repressive role in ccrAB expression and SCCmec excision in MRSA strain N315. Replacement of the IR sequence led to a significant increase in ccrAB expression and curing of SCCmec from strain N315 cells. In addition, we identified the transcriptional regulator SarS using DNA-affinity chromatography and further demonstrated that SarS can bind to the IR sequence and upregulate ccrAB expression and SCCmec excision. These findings reveal a molecular mechanism regulating ccrAB expression and SCCmec excision and may provide mechanic insights into the lateral transfer of SCCmec and spread of antibiotic resistance in S. aureus.
S
taphylococcus aureus is a bacterial pathogen that can cause a variety of infectious diseases, ranging from superficial skin infections to life-threatening septicemia, osteomyelitis, and toxic shock syndrome (1) . Worldwide emergence and spreading of antibiotic-resistant S. aureus pose serious challenges to chemotherapeutic treatment, which were emphasized for many years by methicillin-resistant Staphylococcus aureus (MRSA) strains. MRSA strains are resistant to almost the entire class of ␤-lactam antibiotics due to the acquisition of the staphylococcal cassette chromosome mec (SCCmec) (2) (3) (4) . As a mobile genetic element, SCCmec can be excised from and integrated into the bacterial chromosome (5) , which may subsequently lead to the transfer of methicillin resistance among staphylococcal strains. The phenotype of MRSA is exerted by an alternative penicillin-binding protein, PBP2a, encoded by the mecA gene (6) , which exhibits a much lower affinity to ␤-lactam antibiotics than PBP2 (7) . The mecA gene is located on SCCmec and is regulated by a three-component regulator system, mecR1-mecI-mecR2 (8) , which is also located on SCCmec within the 3= end of the orfX gene coding for 23S rRNA methyltransferase (4, 9) .
Another important gene cluster located on SCCmec is cassette chromosome recombinase genes ccrAB or ccrC, which code for large serine recombinases of the resolvase/invertase family (5, 10) . CcrA, CcrB, and CcrC are three phylogenetically distinct proteins and play a key role in the site-specific excision of SCCmec (11) . While ccrAB are always present together and exist in most SCCmec types, ccrC exists in only a minority of SCCmec types. Interestingly, CcrAB recombinases can excise most SCCmec types (12) , whereas CcrC only plays a role in the excision of a certain type of SCCmec that encodes it (10) . CcrB can bind to the specific sites attS and attB and can interact with CcrA (13) , enabling the recognition of a recombination site without an inverted repeat and mediating SCCmec transfer (11, 14) . According to the combinations of mec gene complex classes and ccr gene complex types, 11 types of SCCmec have been identified to date (15) .
Spontaneous SCCmec excision has been observed on different occasions at low frequency (12, 16, 17) . Although different studies have shown that treatment, such as heating or antibiotic stress, may have effect on ccrAB expression (18, 19) , the regulatory mechanism controlling ccrAB expression remains largely unknown. The expression level of ccrAB remains low under normal growth conditions (18) , and ccrAB is expressed in only a minority of cells (19) , suggesting the existence of a subtle regulatory system. In S. aureus, recent years have seen the findings of complex regulatory networks and novel regulatory factors, such as two-component systems (20) , regulatory RNAs (21), Sar protein families (22) , and alternative sigma factors. Although it has been predicted that the expression of ccrAB was regulated by genetic elements outside SCCmec (19) , transcriptional regulators controlling ccrAB expression have not been identified.
In this study, we identified an inverted repeat (IR) element that is located on almost the same site upstream of the ccrA translation initiation site of different SCCmec types through multiple DNA sequence alignment of various ccrAB promoter sequences. Further study indicated that the IR sequence played a repressive role in ccrAB expression and SCCmec excision. Partial nucleotide substitution of the IR sequence resulted in a significant increase in ccrAB expression and curing of SCCmec from strain N315 cells. Furthermore, a ccrAB promoter-specific binding protein, SarS, was identified by DNA affinity chromatography, and an electrophoretic mobility shift assay (EMSA) further showed that SarS can bind to the IR sequence. In vivo experiments indicated that SarS upregulated ccrAB expression and enhanced SCCmec excision.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . S. aureus strains were grown with aeration (220 rpm) in tryptic soy broth (TSB; Difco) or on tryptic soy agar plates (TSA; Difco) at 37°C. Escherichia coli was grown with aeration (220 rpm) in lysogeny broth medium (LB; Franklin Lakes) or on lysogeny broth agar (LA) at 37°C. When needed, 100 g/ml ampicillin sodium salt or 50 g/ml kanamycin sulfate for E. coli and 15 g/ml chloromycetin for S. aureus strains were supplemented in cultivation.
Construction of LacZ reporter plasmids. To construct the reporter plasmid pOSccrAB for detection of ccrAB expression, a fragment containing the 350-bp promoter of ccrAB and the first 18-bp region of the ccrAcoding sequence was amplified from strain N315 genomic DNA with primers pccrA-f and pccrA-r. The fragment was digested with BamHI/ EcoRI and cloned into the upstream region of the reporter gene lacZ of the shuttle vector pOS1 (23) . To construct the reporter plasmid pOSccrA-BIR1, in which GCCCAACATC was replaced with CGGGAAGATG in the upstream region of the IR sequence for stem-loop structure destruction, the upstream fragment was amplified with primers pccrA-f and pccrAIR1s-r, and the downstream fragment was amplified with primers pccrAIR1s-f and pccrA-r. The two fragments were ligated by SLiCE (24) . Briefly, the two fragments were designed with 20-bp overlaps, and each fragment (50 to 200 ng) was mixed at a molar ratio of 1:1, and then 1 l of 10ϫ SLiCE buffer (500 mM Tris-HCl, 100 mM MgCl 2 , 10 mM dithiothreitol [DTT], pH 7.5), 1 l of SLiCE extract, 1 l of 10 mM ATP, and doubledistilled water (ddH 2 O) were added to a final volume of 10 l. The mixed solution was incubated at 37°C for 1 h and then amplified with primers pccrA-f and pccrA-r. The resultant fragment was digested with BamHI/ EcoRI and cloned into pOS1. To construct the reporter plasmid pOSccrA-BIR2 in which GATGTTGGGC was replaced with CATCTTCCCG in the downstream region of the IR sequence, the upstream fragment was amplified with primers pccrA-f and pccrA-IR2s-r, and the downstream fragment was amplified with primers pccrA-IR2s-f and pccrA-r. The fragment ligated by SLiCE also was amplified with primers pccrA-f and pccrA-r and then digested with BamHI/EcoRI and cloned into pOS1. These reporter plasmids were first transformed into strain RN4220 and then strain N315 or its sarS deletion mutant strain for detection of ccrAB expression.
Construction of overexpression plasmids. To construct the inducible sarS overexpression plasmid, the fragment covering sarS and its ribo- some binding site was amplified from strain N315 genomic DNA with primers sarS-f and sarS-r ( Table 2 ). The fragment was digested with KpnI and cloned into the shuttle vector pRMC2 (25) to obtain pRMCsarS. To construct the ccrAB overexpression plasmid pLIccrAB, a fragment covering ccrAB and the promoter was amplified from strain N315 genomic DNA with primers oe-ccrAB-f and oe-ccrAB-r. The fragment was digested with BamHI and cloned into the shuttle vector pLI50 (26) . To create the ccrAB overexpression plasmid pLIccrAB-IR1, in which the upstream region of the IR sequence was replaced with the same nucleotides as those of pOSccrABIR1, the upstream fragment was amplified with primers oeccrAB-f and pccrA-IR1s-r, and the downstream fragment was amplified with primers pccrA-IR1s-f and oe-ccrAB-r. The two fragments were ligated by SLiCE as described above, and the ligated fragment was amplified with primers oe-ccrAB-f and oe-ccrAB-r, and then the fragment was digested with BamHI and cloned into pLI50. To create the sarS overexpression plasmid pLIsarS, the fragment containing sarS and its promoter was amplified from strain N315 genomic DNA with primers oe-sarS-f and oe-sarS-r, digested with BamHI/HindIII, and cloned into pLI50.
Construction of recombinant strains. To create the sarS and IR sequence mutant strains without extra genes introduced, the plasmid pBTs was used as previously described (27) . To construct the sarS mutant plasmid pBTs⌬sarS, the upstream and downstream regions of sarS were amplified from strain N315 genomic DNA with primer pairs up-sarS-f/upsarS-r and down-sarS-f/down-sarS-r ( Table 2 ). The two fragments were ligated by SLiCE to form an up-down fragment and then cloned into the KpnI/EcoRI-digested plasmid pBTs by SLiCE. To construct the IR mutant plasmid pBTs⌬IR1, in which the upstream region of the IR sequence was replaced with the same nucleotides as those of pOSccrABIR1, the upstream and downstream regions were amplified from strain N315 genomic DNA with primer pairs up-IR1-f/pccrA-IR1s-f and pccrA-IR1s-r/down-IR1-r ( Table 2 ). The two fragments were ligated by SLiCE, and the resultant fragment was digested with EcoRI/KpnI and then cloned into pBTs with T4 ligase. These plasmids were first introduced into strain RN4220 for modification and subsequently transformed into strain N315. The mutant strains were screened using a previously described method (28) and were further confirmed by PCR and sequencing.
␤-Galactosidase assay. For LacZ activity assay with 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) as the substrate, stationary-phase cultures of strain N315 containing different LacZ reporter plasmids were diluted 1:100 into TSB (2 ml) with chloromycetin (15 g/ ml) and X-Gal (40 g/ml). The photos were taken after cultivated for 24 h, 36 h, 48 h, and 60 h, respectively.
TABLE 2 Primers used in this study
Primer Sequence a (5=-3=) Application or reference
CGCggatccTTAGCTAAATGATTCAGTTA pLIsarS oe-sarS-r CCCaagcttATGGTTTTAAGTGATATAGAAA pLIsarS pccrA-r-biotin ATCGGCTCCTCCTTTCACAG Pulldown assay pccrA-fw TTGTCTTTATCATACAACCG Pulldown assay gdpS-f TAGTTCGAACATTTATATACAATA Pulldown assay gdps-r-biotin GGATAGGGTAGACAGATAATAATAATGATACGATTGTCATTAAAACAGTGACATAAGCC Pulldown assay e-sarS-f
ATAAGAATgcggccgcAATGAAATATAATAACCATGACA pEsarS e-sarS-r CCGctcgagTTATTCAAAAACAAGATGTA pEsarS oe-ccrAB-f
GCGggatccCCAAACAACTAAAAGAAGTG pLIccrAB oe-ccrAB-r GCGggatccCCTTCTGCTTCTTCGAATCT pLIccrAB pccrA-r GCGggatccGGGCCTATGACTTGTTTCATAT For ␤-galactosidase assay with o-nitrophenyl-␤-D-galactopyranoside (ONPG) as the substrate, stationary-phase cultures of strain N315 containing different LacZ reporter plasmids were diluted 1:500 into TSB (10 ml) with chloromycetin (15 g/ml), and cells were collected after incubation at 37°C for 6 h, 12 h, 18 h, and 24 h, respectively. First, cells were washed once with ABT buffer (60 mM K 2 HPO 4 , 40 mM KH 2 PO 4 , 100 mM NaCl, 0.1% Triton X-100) and then resuspended in 100 l of ABT-LSA buffer (ABT buffer with 50 g/ml lysostaphin). Cells were treated under shaking conditions at 37°C until thoroughly lysed. The galactosidase activity analysis was performed according to the method described previously (29) .
Oxacillin susceptibility analysis. The oxacillin resistance of strain N315 and its IR mutant strains was analyzed with diffusion disks containing 1 mg of oxacillin at 37°C, and population analysis profiles were determined as previously described (30) .
DNA pulldown assay. DNA pulldown assay was performed as previously described (31, 32) , with minor modifications. Briefly, the biotinlabeled DNA fragment containing the 233-bp promoter region of ccrAB was amplified from strain N315 genomic DNA using primers pccrA-rbiotin and pccrA-fw. The control DNA fragment of gdpS-coding sequence was amplified with primers gdps-r-biotin and gdpS-f. Stationary-phase cultures of strain N315 were diluted 1:500 into TSB (20 ml). Cells were cultivated for 6 h and then collected and washed twice with lysis buffer (10 mM HEPES, 10 mM MgCl 2 , 200 mM NaCl, 1 mM DTT, 1% Triton X-100, pH 7.0) and resuspended in lysis buffer (10 ml) with lysostaphin (10 mM HEPES, 10 mM MgCl 2 , 200 mM NaCl, 1 mM DTT, 1% Triton X-100, 40 U/ml lysostaphin, 10 g/ml DNase I, pH 7.0) under shaking conditions at 37°C for 15 min until thoroughly lysed. The lysate was centrifuged at 12,000 ϫ g at 4°C for 40 min to remove insoluble debris, and the supernatant was concentrated to 2 ml with a Centrifuge Biomax-5 column (Millipore).
The prepared biotin-labeled DNA (25 g) of the ccrAB promoter or control gdpS DNA was coupled to 0.9 ml of streptavidin-coated magnetic beads (Promega) with the same volume of 2ϫ B/W buffer (10 mM TrisHCl, pH 7.5, 1 mM EDTA, 2 M NaCl) at room temperature. After incubation for 1 h, the beads were washed with lysis buffer 3 times to create an atmosphere suitable for protein binding. The supernatant (500 l) with 10 g/ml of poly(dI-dC) was added to the DNA-coated beads and incubated at 4°C for 1 h. The combination of supernatant and DNA-coated beads was repeated once to increase the amount proteins obtained. Beads were washed 5 times with lysis buffer (500 l) containing 10 g/ml of poly(dI-dC) and twice with lysis buffer (500 l), and then it was supplemented with ddH 2 O (70 l) and incubated at 70°C for 10 min. Samples were segregated by SDS-PAGE and detected by silver staining. The specific bands different from the gdpS control were excised and in-gel digested with trypsin (0.6 mg). The tryptic peptides were subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis with an LTQ mass spectrometer (ProteomeX-LTQ; ThermoFisher Scientific). Sequence and peptide fingerprint data were analyzed using the NCBI database.
Expression and purification of SarS. The full-length open reading frame (ORF) of sarS was amplified from strain N315 genomic DNA using primers e-sarS-f and e-sarS-r (Table 2 ) and then cloned into the expression vector pET28a(ϩ) (Novagen) to obtain pEsarS. The plasmid was transformed into E. coli BL21(DE3), and SarS was expressed with the induction of isopropyl-␤-D-1-thiogalactopyranoside (1 mM) at 30°C for 3 h when the culture was grown to an optical density at 600 nm (OD 600 ) of 0.4 to 0.6. The cells then were harvested, resuspended in protein binding buffer (20 mM Tris-HCl, 200 mM NaCl, pH 8.0), and lysed by sonication on ice. SarS was purified using a nickel nitrilotriacetic acid agarose solution (Novagen) with its N-terminal His tag according to the manufacturer's instructions. The bound protein was eluted with elution buffer (20 mM Tris-HCl, 200 mM NaCl, 200 mM imidazole, pH 8.0). The imidazole in the eluent was removed using a Centrifuge Biomax-5 column (Millipore) with the incubation buffer (50 mM Tris-HCl, 200 mM NaCl, pH 8.0), and the protein was stored at Ϫ80°C until use. The protein purity was analyzed using SDS-PAGE, and the protein concentration was determined using the bicinchoninic acid (BCA) assay with bovine serum albumin as the standard. The final concentration of purified SarS was 53 M, which was further used for EMSA.
EMSA. The biotin-labeled DNA fragment containing the promoter region of ccrAB was obtained in the same way as that used for the pulldown assay. The probe containing the IR sequence was obtained through primer fusion of ccrA-IR-sense and ccrA-IR-antisense (Table 2) and then labeled using a digoxigenin (DIG) gel shift kit (Roche). For EMSA, the biotin-labeled promoter of ccrAB (3.5 fmol) or the DIG-labeled IR sequence (10 fmol) was incubated at 25°C for 30 min with various amounts of SarS in 8 l of incubation buffer (50 mM Tris-HCl, 200 mM NaCl, 0.1 mM EDTA, pH 8.0). After incubation, the mixtures were electrophoresed in a 5% or 8% native polyacrylamide gel in 1ϫ Tris-borate-EDTA (TBE) buffer and then transferred to a nylon membrane in 0.5ϫ TBE buffer. The band shifts were detected and analyzed according to the manufacturer's instructions. The images were obtained using an ImageQuant LAS 4000 mini (GE, Piscataway, NJ). The unlabeled fragment of the promoter region was used as a specific competitor at a ratio of approximately 100:1, 50:1, or 500:1 to the labeled fragment. The unlabeled hu fragment was added as a nonspecific competitor.
Total RNA extraction and real-time quantitative reverse transcription-PCR (qRT-PCR). For total RNA isolation from strain N315 with the sarS overexpression plasmid pRMCsarS, stationary-phase culture of strain N315 was diluted 1:100 into TSB (10 ml) with chloromycetin (15 g/ml). Following cultivation for 3 h, cells were treated with anhydrotetracycline at a final concentration of 200 ng/ml for different periods of time and then collected. For total RNA isolation from wild-type strain N315 and the sarS mutant strain, stationary-phase cultures were diluted 1:500 into TSB (10 ml), and the cells grown to different growth phases were collected. The collected cells were immediately treated with 1 ml of RNAiso plus (TaKaRa) and lysed with 0.1-mm-diameter-silica beads in a FastPrep-24 automated system (MP Biomedicals). Total RNA was isolated by following the instructions of RNAiso plus, and residual DNA was removed with RNase-free DNase I (TaKaRa).
For reverse transcription, cDNA was synthesized using a PrimeScript first-strand cDNA synthesis kit (TaKaRa), and qRT-PCR was performed with SYBR Ex Taq premix (TaKaRa) using the StepOne real-time PCR system (Applied Biosystems). The cDNA quantity measured by real-time PCR was normalized to the abundance of hu cDNA (33) . All qRT-PCR assays were repeated at least 3 times.
Determination of the SCCmec excision frequency and the existence of SCCmec. To determine the SCCmec excision frequency, strains carrying pLIccrAB or pLIccrAB-IR1 were cultivated in brain heart infusion (BHI) broth at 37°C for 24 h, cells were collected, and genomic DNA was extracted. The excision frequency was determined by PCR as described previously (34) , and primers from two sides of attB (cL1 and cR1) were used to determine the ratio of the SCCmec-excised populations. Primers with one primer within SCCmec and the other primer in the strain N315 chromosome (mR1 and cL1) were used to determine the ratio of SCCmecretained populations.
In order to determine the SCCmec excision frequency during consecutive cultivation, the strain transformed with pLIsarS was cultivated in BHI broth in consecutive passages at 37°C for 15 days. Cells were collected every 3 days and genomic DNA was extracted. The excision frequency was determined as described above, and strain N315 transformed with the empty shuttle vector pLI50 was used as a control.
To determine if SCCmec was cured from strain N315 cells, the following primer pairs were designed and used for PCR detection. Primer pair cL1 and cR1 was used to detect the attB fragment in SCCmec-excised chromosome, primer pair cL1 and mR1 was used to detect the attL fragment in SCCmec-integrated chromosome, primer pair HVR1 and HVR2 was used to detect the existence of SCCmec in the cells, primer pair mecA1 and mecA2 was used to detect the existence of the mecA gene in the cells, and primer pair SPA1 and SPA2 was used for spa typing.
RESULTS
Identification of a highly conserved IR sequence in ccrAB 5=-untranslated region. Upon analysis of the ccrAB promoter sequence from strain N315, we found a stem-loop structure of a 10-base inverted repeat with a 5-base loop (GCCCAACATCttatt GATGTTGGGC; the 5-base loop is in lowercase), which is located 55 bp upstream of the translation initiation site of ccrA. We compared the ccrAB promoter sequences from 9 different SCCmec types available from NCBI GenBank by multiple-sequence alignment in segments. From the results of the in silico analysis, we found that all of these SCCmec types harbor the IR sequence, which exhibits perfect base pairing, even though there are some base differentiations (Fig. 1A) . Interestingly, an extremely conserved region comprises part of the IR sequence (Fig. 1B) , and all of the IR sequences are located 55 bp (SCCmec types I to IV and IX to XI) or 53 bp (SCCmec types VI and VIII) upstream of the translation initiation site of ccrA (see Fig. S1 in the supplemental material).
The IR sequence played a repressive role in ccrAB expression and SCCmec excision. To determine the effect of the IR sequence on ccrAB expression, we created three different promoter-lacZ reporter gene plasmids. The plasmid pOSccrAB was constructed with the original sequence of the ccrAB promoter, whereas the plasmids pOSccrABIR1 and pOSccrABIR2 were constructed with the base substitution of the upstream or the downstream region of the IR sequence ( Fig. 2A) . Analysis of these strains in TSB containing X-Gal indicated that the replacement of the IR sequence greatly increased the ␤-galactosidase activity, whereas the strain containing the original IR sequence exhibited no visible ␤-galactosidase activity even after cultivation for 60 h (Fig. 2B) . Meanwhile, cells were collected at 6-h intervals to detect ccrAB expression with ONPG. The ␤-galactosidase activity changed dramatically in the strains harboring the substituted IR sequence compared with that of the original IR sequence (Fig. 2C) , indicating that the IR sequence played a repressive role in ccrAB expression. Since the substituted IR sequence enhanced ccrAB expression, it may subsequently affect SCCmec excision. To determine this, we tried to replace the upstream region of the IR sequence in the strain N315 chromosome by using the plasmid pBTs⌬IR1, in which the substituted IR sequence was the same as that of pOSccrABIR1. Surprisingly, PCR analysis with primers spanning the IR sequence showed negative signals in all of these postulated mutant strains, and this phenomenon was further observed in other two separate screenings. We speculated that the replacement of the IR sequence probably had led to high ccrAB expression and, subsequently, SCCmec curing. Since methicillin resistance is an important characteristic of SCCmec, we first evaluated the oxacil- Replacement of the IR sequence greatly increases the ␤-galactosidase activity, whereas the strain containing the original IR sequence exhibited no visible ␤-galactosidase activity. Strains N315 carrying pOSccrAB, pOSccrABIR1, or pOSccrABIR2 were cultivated in TSB containing 40 g/ml X-Gal for different periods of time. Lane 1, strain N315 carrying pOSccrAB (N315 ϩ pOSccrAB); lane 2, strain N315 carrying pOSccrABIR1 (N315 ϩ pOSccrABIR1); lane 3, strain N315 carrying pOSccrABIR2 (N315 ϩ pOSccrABIR2). (C) Partial nucleotide substitution of the IR sequence increases ccrAB expression. Cells were collected at 6-h intervals, and the ␤-galactosidase activity was detected with ONPG. Error bars represent standard deviations (SD) (n ϭ 3). Statistically significant differences calculated by the unpaired two-tailed Student's t test are indicated: NS, not significant (P Ͼ 0.05); *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001. lin resistance of these strains. The results of diffusion disks indicated that the postulated IR mutant strains exhibited reduced resistance (Fig. 3A) , and population analysis profiles revealed that the mutant strains had become susceptible to oxacillin (Fig. 3B) . Further PCR analysis using genomic DNA extracted from the postulated mutant strains and the wild-type strain indicated that SCCmec was cured in all of the bacterial populations we collected (Fig. 3C) .
To further determine if replacement of the IR sequence can lead to SCCmec curing, we evaluated the SCCmec excision frequency using plasmid-driven overexpression. We constructed the plasmid pLIccrAB with the original ccrAB sequence and the plasmid pLIccrAB-IR1 with the upstream region of the IR sequence altered the same way as that for pOSccrABIR1 and pBTs⌬IR1. Our PCR data indicated that the strain carrying pLIccrAB showed significantly higher SCCmec excision frequency than the wild-type strain N315 (Table 3) . Interestingly, replacement of the IR sequence led to almost complete SCCmec curing (Table 3) . These results allow us to conclude that the IR sequence plays a repressive role in ccrAB expression and SCCmec excision.
Identification of a ccrAB promoter binding protein, SarS. In order to identify proteins that are involved in the transcriptional regulation of ccrAB, we performed DNA affinity pulldown assays using a biotin-labeled fragment within ccrAB promoter as the probe. After washing extensively with the nonspecific competitor poly(dI-dC) at a low salt concentration, retained proteins were released by heating with purified water. The solution was analyzed by SDS-PAGE, and the regulatory protein SarS was identified by its mass spectrum (Fig. 4A and Table 4 ).
To confirm the binding ability and specificity, EMSA was performed with the ccrAB promoter labeled with biotin and SarS purified by a nickel nitrilotriacetic acid agarose solution (Fig. 4B) . The results showed that SarS can retard the mobility of the ccrAB promoter in a dose-dependent manner. The protein-DNA complex can be disrupted with a 100-fold concentration of specific competitor, while the same amount of nonspecific competitor did not have the same effect (Fig. 4C) . To further evaluate if SarS can bind to the IR sequence, we prepared a 40-bp DIG-labeled probe containing the whole IR sequence. Our EMSA results indicated that SarS was able to retard the mobility of the probe in a dosedependent manner, and the binding can be disrupted with a 500-fold concentration of specific competitor (Fig. 4D) , implying that the IR sequence is one acting site of SarS. SarS upregulated ccrAB expression and enhanced SCCmec excision. We then created the sarS deletion strain (see Fig. S2 in the supplemental material) and evaluated the effect of SarS on ccrAB expression in the wild-type strain N315 and the sarS mutant strain by qRT-PCR analysis. Compared with the wild-type strain, the sarS mutant strain exhibited no significant difference in ccrA transcription at the exponential phase (Fig. 5A) . In order to explore the effect of SarS on ccrAB expression at the stationary growth phase, we transformed the plasmid pOSccrAB into the N315 and N315⌬sarS strains. The cells were collected at 6-h intervals, and the ␤-galactosidase activity was detected with ONPG as the substrate. The result showed that the ␤-galactosidase activity displayed no difference at 6 h, which was consistent with the qRT-PCR result. However, the ␤-galactosidase activity decreased at the stationary growth phase in the N315⌬sarS strain compared with that of the wild-type strain (Fig. 5B) , suggesting that SarS is involved in the stationary-phase regulation of ccrAB expression. We then determined the effect of SarS on ccrAB transcription by creating the inducible sarS overexpression plasmid pRMCsarS. Cells were collected and total RNA was extracted after induction with anhydrotetracycline for different periods of time. The qRT-PCR assay showed that the transcriptional level of ccrA increased significantly with anhydrotetracycline induction (Fig. 5C) .
To determine the effect of SarS on SCCmec excision, we constructed the sarS overexpression plasmid pLIsarS and transformed it into the N315⌬sarS strain. The transformed cells were cultivated in BHI broth and collected from consecutive cultures every 3 days. Genome DNA was extracted and PCR was performed to measure the SCCmec excision frequency. The results showed that SCCmec excision frequency increased significantly during consecutive cultivation (Fig. 6A) . In contrast, the SCCmec excision frequency remained at almost the same level in the wild-type strain carrying pLI50 (Fig. 6B ). These data indicated that SarS upregulated ccrAB expression and enhanced SCCmec excision.
DISCUSSION
SCCmec is a mobile genetic element and harbors the mecA gene, which codes for an alternative penicillin-binding protein, PBP2a. Acquisition of SCCmec not only gives S. aureus the ability to become resistant to almost the entire class of ␤-lactam antibiotics but also modulates the virulence (35) and agr quorum sensing (36) in some strains. SCCmec types II, III, and VIII and some irregular or truncated SCCmec elements harbor the toxin gene psm-mec (37) , which codes for a regulatory RNA and modulates the virulence of MRSA through suppressing AgrA translation (38) . As displayed before, SCCmec can be excised from or integrated into bacterial chromosomes mediated by CcrAB recombinases, which are encoded by ccrAB genes (5). It has been pointed out that CcrAB-mediated SCCmec excision may enhance the subsequent horizontal transfer of SCCmec and lead the donor strains to a disadvantageous state. Interestingly, ccrAB genes are expressed in only a minority of cells (19) , displaying beneficial effect for both recipient strain and donor strain in genotype spreading and stability. The different expression levels of ccrAB in individual cells suggest that a subtle regulatory mechanism is involved in ccrAB expression and SCCmec excision. The demonstration of regulatory details of ccrAB expression and SCCmec excision should provide insights into the dynamic equilibrium of mobile genetic elements and the emergence of antibiotic resistance in bacteria. In this work, we identified an IR sequence within the ccrAB promoter. Sequence alignment of different SCCmec types indicates that the IR sequence exists extensively among these SCCmec types and is highly conserved both in sequence and location, implying that the IR sequence is a regulator binding site in the ccrAB promoter. Partial replacement of the IR Cells were collected at 6-h intervals, and the ␤-galactosidase activity was detected with ONPG. (C) qRT-PCR analysis of ccrA in strain N315 carrying pRMCsarS with the induction of anhydrotetracycline (ACT; 200 ng/ml). Cells were collected at 0, 5, 15, and 30 min. Error bars represent SD (n ϭ 3). Statistically significant differences calculated by the unpaired two-tailed Student's t test are indicated: NS, not significant (P Ͼ 0.05); *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001. sequence in reporter plasmids enhanced ␤-galactosidase activity, suggesting the repressive effect of this inverted repeat element in the regulation of ccrAB expression. Interestingly, partial substitution of the IR sequence in the chromosome can cause SCCmec curing, further pointing to the significance of the IR sequence in ccrAB expression and SCCmec stability. Notably, substitution of either the upstream region or the downstream region of the IR sequence exhibited the same effect on ccrAB expression, implying that the IR sequence functions through a special secondary structure. Studies have shown that IR elements are widely distributed in S. aureus and play multiple roles in gene regulation by acting as regulatory sites or transcription terminators. A highly conserved IR sequence is present upstream of the int gene in several staphylococcal prophages, fulfilling an important regulatory role (39) . The IR sequence we identified also is located upstream of the putative promoter region, implying a role similar to that of the IR sequence in prophages.
Using DNA pulldown assay, we successfully identified a global transcriptional regulator, SarS, which is a member of the Sar protein family and a downregulator within the SarA/Agr global regulatory network (40, 41) . A previous study has shown that SarS can bind to the promoters of spa, hla, and ssp and greatly promotes the expression of spa and hla (40) . Our results indicated that SarS also can bind to the promoter of ccrAB in a laddering pattern similar to the EMSA results for SarS and the spa promoter (41) . Notably, our further results indicated that SarS can bind to the IR sequence and enhance ccrAB expression and SCCmec excision, revealing the novel role that SarS plays in S. aureus. However, the regulation of ccrAB expression and SCCmec excision seems complicated. Even though we inferred that SarS binds to the IR sequence and affects its structural stability, it cannot be excluded that other regulatory proteins or small regulatory noncoding RNAs may be involved in the regulatory process.
Although S. aureus strain N315 carries intact ccrAB on its chromosome, the spontaneous excision of SCCmec occurs at an extremely low frequency with dynamic equilibrium (19) . The transfer of SCCmec to methicillin-susceptible Staphylococcus aureus (MSSA) poses an advantage to the recipient strain under antibiotic stress, whereas curing of SCCmec poses a disadvantage to the survival of the donor strain. It would be easy to understand that genetic variability occurs in only a minority of cells, which can be precisely controlled through regulation of ccrAB expression. Although SCCmec excision occurs at a very low frequency, the selective pressures promoting the breakup of the dynamic equilibrium would induce a rapid and global expansion of methicillin resistance. Our findings that an inverted repeat DNA element and SarS are involved in the regulation of ccrAB expression and SCCmec excision should provide mechanistic insights into the lateral transfer of SCCmec and expansion of antibiotic resistance in staphylococci. Further identification of molecular regulatory systems and detailed mechanisms controlling ccrAB expression and SCCmec excision may help us understand SCCmec transfer in the environment and develop a novel therapeutic strategy in converting MRSA in vivo into MSSA.
